US Patent 10449236 Treating seizure with recombinant alkaline phosphatase
Patent 10449236 was granted and assigned to Alexion Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 4, 2015
Date of Patent
October 22, 2019
Patent Applicant
Patent Application Number
15532203
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10449236 Treating seizure with recombinant alkaline phosphatase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.